Back
Ultragenyx Pharmaceutical Stock Price Chart
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
31
RARE
Ultragenyx Pharmaceutical
Last Price:
43.38
Seasonality Move:
13.44%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.43 | Sell |
| 20-day SMA: | 47.06 | Sell |
| 50-day SMA: | 48.04 | Sell |
| 200-day SMA: | 42.17 | Buy |
| 8-day EMA: | 45.96 | Sell |
| 20-day EMA: | 47.09 | Sell |
| 50-day EMA: | 47.19 | Sell |
| 200-day EMA: | 44.62 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 39.92 | Sell |
| Chaikin Money Flow: | 437015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.84 - 49.34) | Sell |
| Bollinger Bands (100): | (42.73 - 49.65) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 44.10 while RARE 8-day simple moving average is 47.43, which is a Sell signal.
- The stock price of RARE is 44.10 while Ultragenyx Pharmaceutical 20-day SMA is 47.06, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 48.04 while RARE share price is 44.10, making it a Sell technically.
- RARE stock price is 44.10 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.17, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
31
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $44.10. The Score for RARE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.63B
Price in USD:
44.10
Share Volume:
787.95K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
54.98
52-Week Low:
31.52
Sell
31
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 44.10 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 44.10 while RARE 8-day exponential moving average is 45.96, which is a Sell signal.
- The stock price of RARE is 44.10 while Ultragenyx Pharmaceutical 20-day EMA is 47.09, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 47.19 while RARE share price is 44.10, making it a Sell technically.
- RARE stock price is 44.10 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.62, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and an increase next year of $1.71 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -0.71, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 39.92, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (44.84 - 49.34), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (42.73 - 49.65), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.